10 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
28 Jun 21
Other Events
6:07am
HBsAg with Multiple Potential Mechanisms of Action cccDNA, covalently closed circular DNA; intDNA, integrated DNA; SVPs, subviral particles; HBsAg
10-K
2019 FY
VIR
Vir Biotechnology Inc
26 Mar 20
Annual report
4:08pm
impact on covalently closed circular DNA, or cccDNA, the reservoir for HBV. It has been reported that after a year of therapy with NRTIs, zero to three
424B4
q4s19k14ory0odef7
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
ae8jgk99td x293fd
30 Sep 19
IPO registration (amended)
6:12am
S-1
g2sbamn8nv f4
3 Sep 19
IPO registration
4:40pm
DRS/A
v78s0rdcyo mu9gacq7a
7 Aug 19
Draft registration statement (amended)
12:00am
DRS
2sal5czy
27 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next